A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)
Condition(s):Muscular Dystrophy, DuchenneLast Updated:October 25, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Muscular Dystrophy, DuchenneLast Updated:October 25, 2023Completed
Condition(s):Muscular Dystrophy, Duchenne; DMDLast Updated:August 18, 2020Approved for marketing
Condition(s):Duchenne Muscular Dystrophy; Upper Limb Function; Respiratory Function TestLast Updated:June 12, 2018Completed
Condition(s):Duchenne Muscular DystrophyLast Updated:October 7, 2019Completed
Condition(s):Duchenne Muscular DystrophyLast Updated:January 5, 2024Recruiting
Condition(s):Duchenne Muscular DystrophyLast Updated:September 25, 2017Completed
Condition(s):Muscular Dystrophy, DuchenneLast Updated:July 8, 2019Completed
Condition(s):Duchenne Muscular DystrophyLast Updated:December 8, 2017Terminated
Condition(s):Duchenne Muscular Distrophy (DMD)Last Updated:February 7, 2020Unknown status
Condition(s):Osteoporosis; Duchenne Muscular DystrophyLast Updated:March 16, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.